To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.

To further research how viral ovarian tumor protease (vOTU) activity is critical for replication and host tropism of nairoviruses.

To protect the health of infants and young children by supporting the preclinical development of inactivated rotavirus vaccine.

To provide laboratory support for the analysis of immunogenicity and shedding of new oral Poliovirus vaccines in human clinical trials and related issues for polio endgame.

To provide an evidence base for the food service industry to help navigate the COVID-19 pandemic.

To build capacity of community-based organizations to strengthen vaccine confidence and acceptance within target populations by supporting evidence-based science on vaccinations, vaccine-preventable diseases and the importance of on-time vaccination.

To leverage World Health Organization (WHO) global rotavirus surveillance by using novel technology to achieve a better understanding of the role of enteric pathogens other than rotavirus in childhood diarrhea requiring hospitalization.

To strengthen the surveillance system for the elimination of cholera in Haiti.

To strengthen pregnancy surveillance and service delivery as part of the antenatal and postnatal care research collective at the Child Health and Mortality Prevention Surveillance site in Kenya.

To monitor and evaluate the typhoid conjugate vaccine campaign in Zimbabwe.